PL3386523T3 - Bifidobacterium longum dla leczenia otyłości i powiązanych zaburzeń metabolicznych - Google Patents

Bifidobacterium longum dla leczenia otyłości i powiązanych zaburzeń metabolicznych

Info

Publication number
PL3386523T3
PL3386523T3 PL16820183T PL16820183T PL3386523T3 PL 3386523 T3 PL3386523 T3 PL 3386523T3 PL 16820183 T PL16820183 T PL 16820183T PL 16820183 T PL16820183 T PL 16820183T PL 3386523 T3 PL3386523 T3 PL 3386523T3
Authority
PL
Poland
Prior art keywords
metabolic disorders
bifidobacterium longum
treating obesity
associated metabolic
obesity
Prior art date
Application number
PL16820183T
Other languages
English (en)
Polish (pl)
Inventor
Barry Kiely
Eileen Frances Murphy
Selena HEALY
Original Assignee
Alimentary Health Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alimentary Health Limited filed Critical Alimentary Health Limited
Publication of PL3386523T3 publication Critical patent/PL3386523T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204Probiotics, living bacteria to be ingested for action in the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332Promoters of weight control and weight loss
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL16820183T 2015-12-11 2016-12-09 Bifidobacterium longum dla leczenia otyłości i powiązanych zaburzeń metabolicznych PL3386523T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15199660 2015-12-11
EP16820183.8A EP3386523B1 (en) 2015-12-11 2016-12-09 Bifidobacterium longum for treating obesity and associated metabolic disorders
PCT/EP2016/080454 WO2017097987A1 (en) 2015-12-11 2016-12-09 Bifidobacterium longum for treating obesity and associated metabolic disorders

Publications (1)

Publication Number Publication Date
PL3386523T3 true PL3386523T3 (pl) 2020-03-31

Family

ID=55070675

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16820183T PL3386523T3 (pl) 2015-12-11 2016-12-09 Bifidobacterium longum dla leczenia otyłości i powiązanych zaburzeń metabolicznych

Country Status (14)

Country Link
US (1) US10973862B2 (enExample)
EP (1) EP3386523B1 (enExample)
JP (1) JP6843140B2 (enExample)
KR (1) KR102819885B1 (enExample)
CN (1) CN109069552B (enExample)
AU (1) AU2016368527B2 (enExample)
BR (1) BR112018011665A2 (enExample)
CA (1) CA3006176C (enExample)
DK (1) DK3386523T3 (enExample)
ES (1) ES2760076T3 (enExample)
MX (1) MX378890B (enExample)
PL (1) PL3386523T3 (enExample)
RU (1) RU2740096C2 (enExample)
WO (1) WO2017097987A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016070151A1 (en) 2014-10-31 2016-05-06 Whole Biome. Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
CN110392734A (zh) 2017-02-28 2019-10-29 营养健康有限公司 可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
EP3673044A1 (en) 2017-08-25 2020-07-01 University College Cork-National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス, インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
CN117701424A (zh) * 2018-04-11 2024-03-15 韩国生命工学研究院 具有肥胖预防或治疗效果的新的鼠李糖乳杆菌菌株及其用途
CN113164526A (zh) 2018-07-19 2021-07-23 潘德勒姆治疗公司 用于微生物植入的方法和组合物
KR102224072B1 (ko) * 2019-08-19 2021-03-10 주식회사 빙그레 면역 조절능력과 혈중콜레스테롤 감소 능력이 모두 뛰어난 비피도박테리엄 롱검 아종 균주 및 이의 용도
WO2021180973A1 (en) 2020-03-13 2021-09-16 Precisionbiotics Group Limited Bifidobacterium longum
CN113564069B (zh) * 2021-05-28 2023-09-29 中山大学 一种长双歧杆菌、长双歧杆菌胞外多糖及其提取方法和应用
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
BG67720B1 (bg) * 2022-03-18 2025-04-30 "Ел Би Булгарикум" ЕАД Щам bifidobacterium longum ssp. longum и бифидобактериален препарат с хиполипидемичен ефект, противовъзпалителен имуномодулиращ ефект и с намаляващ инсулиновата резистентност ефект
CN115637237B (zh) * 2022-09-07 2024-09-17 辽宁贝克瑞生物科技有限公司 一株长双歧杆菌及其应用
KR102789455B1 (ko) * 2025-02-05 2025-04-04 주식회사 리스큐어바이오사이언시스 체지방 저감, 혈당 개선 및 근육 기능 강화 활성이 우수한 비피도박테리움 롱검 아종 롱검 lbmb322020 균주 및 이를 포함하는 대사성 질환 예방, 개선 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US8557233B2 (en) 2007-03-28 2013-10-15 Alimentary Heath Limited Probiotic bifidobacterium strains
JP2010526055A (ja) * 2007-05-04 2010-07-29 アリメンタリー・ヘルス・リミテッド エキソ多糖
ES2566496T3 (es) * 2008-11-11 2016-04-13 Alimentary Health Limited Bifidobacterium longum
EP2308499A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Bifidobacterium longum ATCC BAA-999 (BL999) and weight control
CA2779418C (en) * 2009-11-11 2018-03-20 Alimentary Health Limited Probiotic bifidobacterium strain
CA3092318A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Also Published As

Publication number Publication date
RU2018119287A (ru) 2020-01-13
WO2017097987A1 (en) 2017-06-15
DK3386523T3 (da) 2020-01-06
MX378890B (es) 2025-03-10
US20190111090A1 (en) 2019-04-18
CA3006176A1 (en) 2017-06-15
JP6843140B2 (ja) 2021-03-17
CA3006176C (en) 2023-10-31
CN109069552B (zh) 2023-01-24
CN109069552A (zh) 2018-12-21
MX2018006905A (es) 2018-08-24
RU2740096C2 (ru) 2021-01-11
AU2016368527B2 (en) 2023-01-12
JP2018536427A (ja) 2018-12-13
KR20180083352A (ko) 2018-07-20
AU2016368527A1 (en) 2018-07-12
RU2018119287A3 (enExample) 2020-06-30
EP3386523B1 (en) 2019-10-09
EP3386523A1 (en) 2018-10-17
US10973862B2 (en) 2021-04-13
BR112018011665A2 (pt) 2018-12-04
KR102819885B1 (ko) 2025-06-12
ES2760076T3 (es) 2020-05-13

Similar Documents

Publication Publication Date Title
PL3386523T3 (pl) Bifidobacterium longum dla leczenia otyłości i powiązanych zaburzeń metabolicznych
HUS2500022I1 (hu) Terápiás ellenanyagok és alkalmazásaik
IL251066B (en) Preparations and methods for the treatment of metabolic disorders
PL3387156T3 (pl) Lactobacillus casei do leczenia otyłości i powiązanych zaburzeń metabolicznych
ZA201700311B (en) Compositions and methods of use for treating metabolic disorders
DK3223835T3 (en) Intestinal microbiota and gvhd
IL253782A0 (en) Recombinant probiotic bacteria
IL258005A (en) Methods and materials for gene therapy for beta-4,1-en.-acetylgalactosaminyltransferase 2
PT3277295T (pt) Composição para o tratamento de um estado metabólico patogénico da flora intestinal e de doenças derivadas
PL3209307T3 (pl) Kompozycje probiotyczne i prebiotyczne
EP3142699A4 (en) Compositions and methods for treating metabolic disorders
GB201406172D0 (en) Therapy and pharmaceutical composition
PL3445362T3 (pl) Kompozycja i sposób leczenia zaburzeń metabolicznych
GB201501202D0 (en) Novel methods for diagnosis and therapy
GB201414706D0 (en) Calcitonin mimetics for treating diseases and disorders